Journal
CELL REPORTS
Volume 38, Issue 7, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2022.110388
Keywords
-
Categories
Funding
- National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) [5R01AI152192-02, 5R01AI137424-03, F31AI152460-01]
- Department of Defense [PR192269]
Ask authors/readers for more resources
In this study, using a murine model, we identified the immune protection factors against POWV infection and demonstrated that robust B and T cell responses are necessary for immune protection. These immune protection factors were applied in a virus-like particle (VLP)-based vaccination approach, providing protection against lethal POWV challenge.
Powassan virus (POWV) is a tick-borne pathogen for which humans are an incidental host. POWV infection can be fatal or result in long-term neurological sequelae; however, there are no approved vaccinations for POWV. Integral to efficacious vaccine development is the identification of correlates of protection, which we accomplished in this study by utilizing a murine model of POWV infection. Using POWV lethal and sublethal challenge models, we show that (1) robust B and T cell responses are necessary for immune protection, (2) POWV lethality can be attributed to both viral-and host-mediated drivers of disease, and (3) knowledge of the immune correlates of protection against POWV can be applied in a virus-like particle (VLP)-based vaccination approach that provides protection from lethal POWV challenge. Identification of these immune protection factors is significant as it will aid in the rational design of POWV vaccines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available